The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 11, 2017
Filed:
Mar. 27, 2014
Applicant:
Taiho Pharmaceutical Co., Ltd., Chiyoda-ku, JP;
Inventor:
Hiroyuki Okabe, Hanno, JP;
Assignee:
TAIHO PHARMACEUTICAL CO., LTD., Chiyoda-ku, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A01N 43/04 (2006.01); A61K 31/7072 (2006.01); A61K 31/4745 (2006.01); A61K 31/506 (2006.01); A61K 31/513 (2006.01); A61K 31/706 (2006.01); A61K 31/7064 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7072 (2013.01); A61K 31/4745 (2013.01); A61K 31/506 (2013.01); A61K 31/513 (2013.01); A61K 31/706 (2013.01); A61K 31/7064 (2013.01); A61K 31/7068 (2013.01);
Abstract
Provided is a novel combination therapy using an FTD/TPI combination drug which exhibits remarkable antitumor effects, and few side effects. An antitumor agent is characterized in that the FTD/TPI combination drug is administered, using a reduced amount of trifluridine, at a dose in the range of 35 to 70 mg/m/day and CPT-11 is administered at a dose in the range of 45 to 144 mg/m/day.